The evanescence and persistence of RBC alloantibodies in blood donors-Reference-Cited by-同舟云学术

The evanescence and persistence of RBC alloantibodies in blood donors

Published:2020-02-15 Issue:4 Volume:60 Page:831-839
ISSN:0041-1132
Container-title:Transfusion
language:en
Short-container-title:Transfusion

Author:

Hauser Ronald G.¹²,Esserman Denise³,Karafin Matthew S.⁴⁵^ORCID,Tan Sylvia⁶,Balbuena‐Merle Raisa¹²^ORCID,Spencer Bryan R.¹⁷,Roubinian Nareg H.⁸⁹^ORCID,Wu Yanyun¹¹⁰^ORCID,Triulzi Darrell J.¹¹,Kleinman Steve¹²,Gottschall Jerome L.⁴⁵,Hendrickson Jeanne E.¹¹³^ORCID,Tormey Christopher A.¹²^ORCID,

Affiliation:

1. Yale UniversityDepartment of Laboratory Medicine New Haven Connecticut

2. Department of Pathology & Laboratory Medicine ServiceVeterans Affairs Connecticut Healthcare System West Haven Connecticut

3. Department of BiostatisticsYale School of Public Health New Haven Connecticut

4. Versiti Milwaukee Wisconsin

5. Department of Pathology & Laboratory MedicineMedical College of Wisconsin Milwaukee Wisconsin

6. RTI International Rockville Maryland

7. American Red Cross Scientific Affairs Dedham Massachusetts

8. Department of Laboratory MedicineUniversity of California San Francisco California

9. Blood Systems Research Institute San Francisco California

10. Bloodworks Northwest Seattle Washington

11. University of Pittsburgh and Vitalant Pittsburgh Pennsylvania

12. Department of Pathology and Laboratory MedicineUniversity of British Columbia Vancouver British Columbia Canada

13. Department of PediatricsYale University New Haven Connecticut

Publisher

Wiley

Subject

Hematology,Immunology,Immunology and Allergy

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/trf.15718

Reference21 articles.

1. Red Blood Cell Alloimmunization Mitigation Strategies

2. The persistence and evanescence of blood group alloantibodies in men

3. US Department of Health and Human Services. Fatalities reported to the FDA following blood collection [Internet]. Rockville (MD): FDA. [cited 2019 Nov 17]. Available from:https://www.fda.gov/vaccines-blood-biologics/report-problem-center-biologics-evaluation-research/transfusiondonation-fatalities.

4. Delayed haemolytic and serologic transfusion reactions

5. Estimating the immunogenicity of blood group antigens: a modified calculation that corrects for transfusion exposures

Cited by 16 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Characterising the challenges of managing difficult red blood cell alloantibodies in liver transplant recipients;Journal of Clinical Pathology;2024-05-15

2. Complement C3 and marginal zone B cells promote IgG-mediated enhancement of RBC alloimmunization in mice;Journal of Clinical Investigation;2024-04-15

3. Evaluation of the Analytical Performance of Immulab, Bio-Rad, Grifols and Quidelortho Reagent Blood Cells in Antibody Screening and Identification;2024

4. Does decreasing the incubation period used in the antibody screen affect its sensitivity?;Transfusion Medicine;2023-09-20

5. Implementation of a molecular genotyping protocol for patients with warm autoantibodies;Transfusion;2023-06-28